RE:RE:RE: Boehringer Ingelheim With product from all 8 suppliers below, the PGX process was able to produce an identical end product that met spec. This gives CZO a lot of lattitude with suppliers, supply input risk is greatly diminished.
prophetoffactz wrote: CZO might have to commit to a YBG supplier for the fibrosis drug now as it also signs a deal for PGX-YBG/CoQ10, etc.